Levosulpiride
NERVOUS SYSTEM
Also known as: (-)-Sulpiride, L-Sulpiride, lesuride, levobren, levopraid, levopride
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Levosulpiride is a drug catalogued in DrugCentral. DrugCentral lists 9 molecular targets, including Drd2, DRD2 and DRD3.
- Molecular targets: Drd2, DRD2, DRD3 and Drd1|Drd3|Drd5|Drd4|Drd2 (9 listed in DrugCentral).
- ATC code: N05AL07 (Benzamides).
- Molecular formula: C15H23N3O4S; molecular weight 341.43 g/mol.
Mechanism & targets
Molecular targets (9)
| Target | Gene | Action | Activity |
|---|---|---|---|
| D(2) dopamine receptor | Drd2 | unknown | Ki 8.16 |
| D(2) dopamine receptor | DRD2 | unknown | Ki 7.29 |
| D(3) dopamine receptor | DRD3 | unknown | Ki 7.06 |
| Dopamine receptor | Drd1|Drd3|Drd5|Drd4|Drd2 | unknown | IC50 6.68 |
| D(4) dopamine receptor | DRD4 | unknown | Ki 5.68 |
| Myeloperoxidase | MPO | unknown | IC50 5.12 |
| Adrenergic receptor alpha-1 | Adra1b|Adra1d|Adra1a | unknown | Ki 4.82 |
| Serotonin 2 (5-HT2) receptor | Htr2c|Htr2a|Htr2b | unknown | Ki 4.57 |
| D(1A) dopamine receptor | DRD1 | unknown | Ki 4.30 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N05AL07 | NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Benzamides |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Sopor | 121.5 |
| Cerebellar syndrome | 88.6 |
| Disorganised speech | 76.8 |
| Galactorrhoea | 76.0 |
| Renal ischaemia | 74.8 |
| Drug abuse | 62.3 |
| Necrotising colitis | 58.8 |
| Hyperprolactinaemia | 54.2 |
| Serotonin syndrome | 53.0 |
| Drug interaction | 45.7 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Levosulpiride is on its molecule page.
| Molecular formula | C15H23N3O4S |
|---|---|
| Molecular weight | 341.43 g/mol |
| CAS number | 23672-07-3 |
| InChIKey | BGRJTUBHPOOWDU-NSHDSACASA-N |
| PubChem CID | 688272 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Levosulpiride work?
Its molecular targets in DrugCentral include Drd2, DRD2, DRD3 and Drd1|Drd3|Drd5|Drd4|Drd2.
What is the chemical formula of Levosulpiride?
Levosulpiride has the molecular formula C15H23N3O4S and a molecular weight of 341.43 g/mol.
Browse: all drugs starting with L · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1577 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL267044 — compound record and bioactivity
- PubChem CID 688272 — chemical identifiers
- DrugBank DB16021 — drug record
- FDA UNII JTG7R315LK — substance identity
- UniProt P14416 (DRD2) — target protein
- UniProt P35462 (DRD3) — target protein
- UniProt P21917 (DRD4) — target protein
- UniProt P05164 (MPO) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.